Neurogene (NASDAQ:NGNE) Price Target Raised to $72.00 at Leerink Partners
Neurogene (NASDAQ:NGNE – Free Report) had its price target hoisted by Leerink Partners from $45.00 to $72.00 in a research report released on Tuesday,Benzinga reports. Leerink Partners currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Robert W. Baird boosted their target price on Neurogene from […]
More Stories
TD SYNNEX (NYSE:SNX) Stock Price Up 5.4% – Should You Buy?
Shares of TD SYNNEX Co. (NYSE:SNX – Get Free Report) were up 5.4% on Friday . The stock traded as...
Endeavour Silver (NYSE:EXK) Trading 6.2% Higher – Should You Buy?
Endeavour Silver Corp. (NYSE:EXK – Get Free Report) (TSE:EDR) shot up 6.2% during mid-day trading on Friday . The company...
LyondellBasell Industries (NYSE:LYB) Shares Purchased by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its holdings in LyondellBasell Industries (NYSE:LYB – Free Report) by 20.2% during the 4th quarter, according...
Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO) Shares Bought by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO – Free Report) by 98.5%...
Ridgewood Investments LLC Decreases Holdings in Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV)
Ridgewood Investments LLC trimmed its stake in shares of Invesco S&P International Developed Low Volatility ETF (NYSEARCA:IDLV – Free Report)...
Smith & Nephew plc (NYSE:SNN) Stock Position Lifted by Ridgewood Investments LLC
Ridgewood Investments LLC boosted its stake in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 6.1% during...